Huperzine A/Huperzia serrata / Casp3 Cancer Research Results

Hup, Huperzine A/Huperzia serrata: Click to Expand ⟱
Features:
huperzine A is a natural product and has been studied for its potential benefits in Alzheimer's disease (AD).
-inhibits acetylcholinesterase(AChE), the enzyme that breaks down acetylcholine, a key neurotransmitter involved in memory and learning.

Huperzine A (Huperzia serrata) – Alzheimer's Disease (AD) Pathway Matrix

Rank Pathway / Axis AD Direction Mechanism Snapshot TSF Evidence Notes / Clinical Relevance
1 AChE Inhibition ACh ↑ Potent reversible acetylcholinesterase inhibitor → increases synaptic acetylcholine P, R Human trials (moderate) Primary mechanism; similar functional class to donepezil. Improves memory and cognition scores in mild–moderate AD.
2 NMDA Receptor Modulation Excitotoxicity ↓ Partial antagonistic modulation of NMDA receptor signaling R Preclinical + supportive Reduces glutamate-mediated excitotoxicity; complementary to cholinergic effects.
3 Mitochondrial Protection Mito dysfunction ↓ Preserves mitochondrial membrane potential; reduces cytochrome c release R, G Preclinical Supports neuronal survival under oxidative stress conditions.
4 ROS Modulation ROS ↓ (neuronal models) Reduces oxidative stress markers; improves antioxidant enzyme activity R, G Preclinical Neuroprotective antioxidant effect; contrasts with pro-oxidant effect in some cancer cells.
5 Aβ Toxicity Modulation Aβ neurotoxicity ↓ Reduces Aβ-induced neuronal apoptosis G Preclinical Protects against Aβ-mediated mitochondrial and synaptic injury.
6 Tau Pathology p-tau ↓ (model data) Indirect reduction of hyperphosphorylated tau via neuroprotective signaling G Limited preclinical Not a primary anti-tau agent but supportive.
7 BDNF Support BDNF ↑ (indirect) Enhances synaptic plasticity signaling G Preclinical Supports cognitive resilience.
8 Neuroinflammation IL-1β ↓, TNF-α ↓ (model data) Reduces pro-inflammatory cytokines in brain models G Preclinical Anti-inflammatory contribution secondary to cholinergic signaling.

Time-Scale Flag (TSF):
P = 0–30 min (enzyme inhibition)
R = 30 min–3 hr (neurotransmission / mitochondrial signaling shifts)
G = >3 hr (synaptic plasticity, inflammation modulation, neuroprotection)
Casp3, CPP32, Cysteinyl aspartate specific proteinase-3: Click to Expand ⟱
Source:
Type:
Also known as CP32.
Cysteinyl aspartate specific proteinase-3 (Caspase-3) is a common key protein in the apoptosis and pyroptosis pathways, and when activated, the expression level of tumor suppressor gene Gasdermin E (GSDME) determines the mechanism of tumor cell death.
As a key protein of apoptosis, caspase-3 can also cleave GSDME and induce pyroptosis. Loss of caspase activity is an important cause of tumor progression.
Many anticancer strategies rely on the promotion of apoptosis in cancer cells as a means to shrink tumors. Crucial for apoptotic function are executioner caspases, most notably caspase-3, that proteolyze a variety of proteins, inducing cell death. Paradoxically, overexpression of procaspase-3 (PC-3), the low-activity zymogen precursor to caspase-3, has been reported in a variety of cancer types. Until recently, this counterintuitive overexpression of a pro-apoptotic protein in cancer has been puzzling. Recent studies suggest subapoptotic caspase-3 activity may promote oncogenic transformation, a possible explanation for the enigmatic overexpression of PC-3. Herein, the overexpression of PC-3 in cancer and its mechanistic basis is reviewed; collectively, the data suggest the potential for exploitation of PC-3 overexpression with PC-3 activators as a targeted anticancer strategy.
Caspase 3 is the main effector caspase and has a key role in apoptosis. In many types of cancer, including breast, lung, and colon cancer, caspase-3 expression is reduced or absent.
On the other hand, some studies have shown that high levels of caspase-3 expression can be associated with a better prognosis in certain types of cancer, such as breast cancer. This suggests that caspase-3 may play a role in the elimination of cancer cells, and that therapies aimed at activating caspase-3 may be effective in treating certain types of cancer.
Procaspase-3 is a apoptotic marker protein.
Prognostic significance:
• High Cas3 expression: Associated with good prognosis and increased sensitivity to chemotherapy in breast, gastric, lung, and pancreatic cancers.
• Low Cas3 expression: Linked to poor prognosis and increased risk of recurrence in colorectal, hepatocellular carcinoma, ovarian, and prostate cancers.
Scientific Papers found: Click to Expand⟱
4209- Hup,    Huperzine A, reduces brain iron overload and alleviates cognitive deficit in mice exposed to chronic intermittent hypoxia
- in-vivo, NA, NA
*ROS↓, *cognitive↑, *neuroP↑, *Bax:Bcl2↓, *Casp3↑, *NADPH↓, *NOX↓, *TfR1/CD71↓, *Iron↓, *PSD95↑, *BDNF↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

Iron↓, 1,   ROS↓, 1,  

Metal & Cofactor Biology ⓘ

TfR1/CD71↓, 1,  

Core Metabolism/Glycolysis ⓘ

NADPH↓, 1,  

Cell Death ⓘ

Bax:Bcl2↓, 1,   Casp3↑, 1,  

Cellular Microenvironment ⓘ

NOX↓, 1,  

Synaptic & Neurotransmission ⓘ

BDNF↑, 1,   PSD95↑, 1,  

Functional Outcomes ⓘ

cognitive↑, 1,   neuroP↑, 1,  
Total Targets: 11

Scientific Paper Hit Count for: Casp3, CPP32, Cysteinyl aspartate specific proteinase-3
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:343  Target#:42  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page